August 4, 2014
Is Valeant’s Offer for Allergan the New Roadmap for Biopharma Acquisitions?
Pharmaceutical Compliance Monitor publishes “Is Valeant’s Offer for Allergan the New Roadmap for Biopharma Acquisitions?”, written by Partner Nicholas O’Keefe.
